comparemela.com

Alida Caforio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

For less-sick patients, results from the ACT trials showed no benefits with colchicine, aspirin, or rivaroxaban plus aspirin.

United statesSao pauloComunidad autonoma de catalunaDphil brighamErin bohulaDavid bergJohn eikelboomSanjit jollyAlida caforioEduardo ramacciottiEuropean society of cardiology congressMcmaster universityMd university of sheffieldInternational society on thrombosisPhd university of padovaPhd science valley research institute

Full-Dose Anticoagulation Cuts VTE in Severe COVID-19

But is it worthwhile without a mortality benefit? Trials present complex picture

United statesComunidad autonoma de catalunaJohn william eikelboomDavid bergSanjit jollyAlida caforioEduardo ramacciottiMcmaster universityEuropean society of cardiologyInternational society on thrombosisPopulation health research instituteScience valley research institute in santo andrUniversity of paduaEuropean societyGlobal useOpen occluded arteries

vimarsana © 2020. All Rights Reserved.